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1. INTRODUCTION 
Evidences from clinical and epidemiological studies 
have clearly established that obesity is the most common 
cause of insulin resistance, type 2 diabetes mellitus 
(T2DM) and non-alcoholic fatty liver disease (NAFLD). In 
fact, insulin resistance in peripheral tissues such as liver 
and skeletal muscle is an early metabolic abnormality in 
the development of T2DM (1). Although the precise 
molecular mechanisms underlying insulin resistance 
associated to obesity have not been completely elucidated, 
one major contributor is the chronic low-grade systemic 
inflammation state which interferes with the early steps of 
the insulin signaling cascade possibly through the effects 
of free fatty acids (FFAs) and cytokines secreted by the 
overgrowing white adipose tissue (WAT) (2-4). 
Proinflammatory cytokines impair insulin action by 
activating stress kinases such as c-jun (NH2) terminal 
kinase (JNK), IκB kinase (IKK) and also protein kinase C 
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RESUMEN: La inflamación crónica de bajo grado en el 
tejido adiposo durante la obesidad se asocia a una 
disminución de la señalización de la insulina. Hemos 
evaluado el impacto de la estimulación de los 
macrófagos con oleato o palmitato y el efecto sobre la 
lipoapoptosis y la señalización de la insulina en los 
hepatocitos. Los macrófagos y las células de Kupffer se 
estimularon con dichos ácidos grasos para analizar los 
niveles de marcadores de polarización M1/M2. Los 
macrófagos estimulados con oleato presentaron mayores 
niveles de marcadores antiinflamatorios, mientras que 
los tratados con palmitato presentaron una elevada 
expresión de citoquinas proinflamatorias. Tras el 
tratamiento de los hepatocitos con medio condicionado 
de macrófagos estimulados con palmitato (CM-P) 
detectamos un incremento en la fosforilación de las 
quinasas de estrés y marcadores de estrés del retículo 
endoplásmico (ER), junto con un aumento en la 
lipoapoptosis y un bloqueo en la señalización de la 
insulina. Por el contrario, en hepatocitos tratados con el 
medio condicionado de macrófagos estimulados con 
oleato (CM-O) observamos un aumento en la 
señalización de la insulina y una reducción en los 
niveles de la proteína fosfatasa 1B (PTP1B). En 
conclusión, oleato y palmitato desencadenan respuestas 
opuestas entre los macrófagos y los hepatocitos. 
Mientras que el CM-P bloquea las primeras etapas de la 
señalización de la insulina, el CM-O aumenta la 
sensibilidad a la insulina disminuyendo la PTP1B. Por 
tanto, la inhibición de PTP1B es una estrategia 
terapéutica para combatir la resistencia a la insulina en 
el hígado en estados de obesidad. 
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(PKC)-mediated pathways (5, 6). In addition, cytokines 
down-regulate early key mediators of the insulin signaling 
cascade such as the insulin receptor (IR) or insulin 
receptor substrate 1 (IRS1) (7, 8), as well as increase the 
expression of negative modulators of this pathway such as 
the protein tyrosine phosphatase 1B (PTP1B) (9, 10). On 
the other hand, circulating FFAs, which are usually 
increased in insulin resistant states (11-13), also activate 
these proinflammatory pathways boosting the defects in 
peripheral insulin actions (14-16). 
In addition to the inflammatory effects, the activation 
of endoplasmic reticulum (ER) stress-mediated signaling 
pathways by FFAs has been linked to obesity-associated 
immunometabolic dysregulation and insulin resistance (17, 
18). ER stress is sensed by three main proteins: X-box 
binding protein 1 (X-BP1), PRKR-like endoplasmic 
reticulum kinase (PERK) and activating transcription 
factor-6 (ATF6), which cooperate to mitigate ER stress by 
reducing protein translation, stabilizing proteins by 
chaperones and activating ER-associated protein 
degradation (19). Chemical chaperones 
(tauroursodeoxycholic acid (TUDCA) and 4-
phenylbutryate) that alleviate ER stress through protein 
stabilization, improve systemic glucose homeostasis, 
increase glucose uptake in adipose and skeletal muscle and 
reduce hepatic glucose production (20). Moreover, a study 
in obese subjects has revealed that treatment with TUDCA 
increases insulin sensitivity in liver and skeletal muscle by 
approximately 30% compared to the placebo therapy (21). 
Several studies have reported that besides adipocytes, 
adipose tissue resident macrophages, which migrate and 
accumulate in WAT, have a relevant role in obesity-
induced chronic inflammation (22-24) through their 
polarization toward the M1-like state (25). Although the 
importance of macrophages in the molecular mechanisms 
triggering insulin resistance in skeletal muscle and adipose 
tissue has been explored (25-27), it remains unclear 
whether the inflammatory milieu from hepatic 
macrophages impact insulin signaling in hepatocytes. On 
that basis, in this study we have investigated for the first 
time the effect of Kupffer cells activated by two distinct 
FFAs, palmitate (saturated) and oleate (unsaturated), on 
stress-mediated pathways, lipoapoptosis and the insulin 
signaling cascade in hepatocytes.  
2. MATERIALS AND METHODS 
2.1. Reagents  
Fetal bovine serum (FBS) (#10270) and culture media 
DMEM (#41966-029) were obtained from Invitrogen (Life 
Technologies, Gran Island, NY). TRIzol reagent (#T9424), 
sodium palmitate (#P9767), sodium oleate (#O7501), 
bovine serum albumin (BSA) (#A6003), fatty acid free-
BSA endotoxin free (#A8806) and insulin (#I0516) were 
from Sigma Aldrich (St. Louis, MO). Bradford reagent, 
acrylamide, immunobloting PVDF membrane and 
Immobilon Western Chemiluminescent HRP Substrate 
were purchased from Bio-Rad (Hercules, CA). 
2.2. Free fatty acid preparation  
2.5 mM free fatty acid (FFA) stock solutions were 
prepared by modification of Spector method (28). Briefly, 
cold sodium palmitate or sodium oleate were dissolved in 
0.1M NaOH by heating at 70°C while 0.5 mM BSA 
solution was prepared by dissolving fatty acid free-BSA in 
NaCl 0.9% by heating at 50°C (at maximum). Once BSA 
and FFA solutions were completely dissolved, palmitate 
and oleate solutions were diluted 10-times in the BSA 
solution and mixed by pipetting to achieve a final molar 
ratio of 5:1. Control BSA was prepared by adding the 
same amount of 0.1M NaOH into 0.5 mM BSA solution. 
All preparations were filtered, aliquoted and stored at –
20°C. 
2.3. Culture of RAW 264.7 murine macrophages 
Murine RAW 264.7 macrophage cell line, kindly 
provided by Dr. Tarín (CNIC, Madrid, Spain), were 
cultured in RPMI supplemented with 10% heat inactivated 
FBS, 100 U/ml penicillin, 100 µg/ml streptomycin and 2 
mM glutamine. Confluent macrophages were treated with 
BSA or FFAs solutions (750 µM conjugated oleate/BSA 
or 750 µM conjugated palmitate/BSA) for 24 h to obtain 
the corresponding conditioned media (CM) (27). CM were 
centrifuged to remove dead cells and directly added 
(without dilution) to hepatocytes for several time periods. 
2.4. Isolation and culture of Kupffer cells  
Kupffer cells were obtained from livers of 3 months-
old male C57/BL6 mice. All animal experimentation has 
been conducted according to the Guide of the care and use 
of laboratory animals (National Academy of Sciences, 
USA). For Kupffer cells (KC) isolation, the supernatant 
from the first centrifugation of the hepatocyte isolation 
protocol was collected and centrifuged twice at 50 x g for 
5 min to discard the pellet with the remaining hepatocytes. 
The latest supernatant was centrifuged at 500 x g for 5 min 
at 4ºC and the pellet containing the KC was resuspended in 
attachment media. Cells were mixed by inversion with 
50% percoll and centrifuged at 1.000 x g for 30 min 
without acceleration or brake at room temperature. Finally, 
KC pellet was washed with PBS 1X, centrifuged twice at 
500 x g for 10 min at 4ºC to wash out the residual percoll 
solution and cells were resuspended in RPMI 
supplemented with 10% heat inactivated FBS, 100 U/ml 
penicillin, 100 µg/ml streptomycin and 2 mM glutamine. 
Cells were then plated on 12 well-plates and maintained 
for 24 h before treatments. Conditioned media was 
prepared as described in RAW 264.7 cells. 
2.5. Hepatocyte cell culture.  
Human hepatocytes were isolated by the two-step 
collagenase procedure from non-tumor areas of liver 
biopsies from patients submitted to a surgical resection for 
liver tumours after obtaining patients' written consent (29). 
Primary mouse hepatocytes were isolated from non-fasting 
male C57BL/6 mice (10-12-week-old) by perfusion with 
collagenase as described (30). Cells were seeded on 6 
well-plate (Corning, New York, NY) and cultured in 
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media containing Dulbecco's modified Eagle's medium 
and Ham's F-12 medium (1:1) with 10% FBS, 
supplemented with 2 mm glutamine, 100 U/ml penicillin, 
100 µg/ml streptomycin and 1 mM sodium pyruvate 
(attachment media) and maintained for 24 h before 
treatments. The generation and characterization of 
immortalized mouse hepatocyte cell line has been 
previously described (31). Cells were grown in DMEM 
plus 10% heat inactivated FBS, 100 U/ml penicillin, 100 
µg/ml streptomycin and 2 mM glutamine. 
2.6. Preparation of protein extracts and Western blot  
To obtain total cell lysates, attached cells were scraped 
off and incubated for 10 min on ice with lysis buffer (25 
mM HEPES, 2.5 nM EDTA, 0.1% Triton X-100, 1 mM 
PMSF and 5 µg/ml leupeptin). After protein content 
determination with Bradford reagent, total protein were 
boiled in Laemmli sample buffer and submitted to 8-15% 
SDS-PAGE. Proteins were transferred to Immunoblot 
PVDF membrane and, after blocking with 3% BSA or 5% 
non-fat dry milk, membranes were incubated overnight 
with several antibodies as indicated. Immunoreactive 
bands were visualized using the ECL Western blotting 
protocol. Densitometric analysis of the bands was 
performed using Image J software. The anti-phospho-
PERK (Thr 980) (#3179), anti-phospho-eIF2α (Ser 51) 
(#9721), anti-phospho-JNK (#9251), anti-phospho-STAT3 
(#9131) antibodies were from Cell Signaling Technology 
(Danvers, MA). The anti-JNK (sc-571), anti-IR β (sc-711), 
anti-eIF2α (sc-11386), anti-CHOP (sc-7351), anti-
phospho-p38 (sc-17852), anti-p38 (sc-9212), anti-IRS1 
(sc-559), anti-phospho-IR (sc-25103), anti-phospho-Akt 
(Thr 308) (sc-16646), anti-phospho-Akt (Ser 473) (sc-
7985), anti-Akt (sc-8312) and anti-PTP1B (sc-1718) 
antibodies were from Santa Cruz Biotechnology (Santa 
Cruz, CA). Anti-α-tubulin (T5168) was from Sigma 
Aldrich (St. Louis, MO). 
2.7. RNA isolation and qPCR  
Total RNA was isolated using Trizol reagent and was 
reverse transcribed using a SuperScriptTM III First-Strand 
Synthesis System for qPCR following manufacturer’s 
indications. qPCR was performed with an ABI 7900 
sequence detector using the SyBr Green method and d(N)6 
random hexamer with primers purchased from Invitrogen. 
PCR thermocycling parameters were 95°C for 10 minutes, 
40 cycles of 95°C for 15 seconds, and 60°C for 1 minute. 
Each sample was run in triplicate and normalized to 18s 
RNA. Fold changes were determined using the ∆∆Ct 
method. Primer sequences are available upon request. 
2.8. Statistical analysis  
Data are presented as mean ± SEM, and were 
compared by using the Bonferroni ANOVA test. All 
statistical analyses were performed using the IBM SPSS 
Statistics 21.0 (SPSS Inc. IBM, Armonk, NY) software 
with 2-sided tests. Differences were considered 
statistically significant at p<0.05. 
 
3. RESULTS AND DISCUSSION 
RESULTS 
3.1. Insulin signaling is opposite modulated in human 
hepatocytes pretreated with conditioned medium from 
macrophages stimulated with palmitate or oleate  
The liver is composed primarily of hepatocytes, but 
also contains blood and lymph vessels, nerves and immune 
cells. Since all these cell types can potentially respond to a 
high fat-mediated inflammatory environment in vivo, we 
performed a cell culture-based approach to investigate the 
specific cross-talk between macrophages and hepatocytes 
in the context of fatty acid overload. For this goal, RAW 
264.7 macrophages were treated with palmitate, a typical 
saturated FFA found in western diets, for 24 h. Then, 
culture media (conditioned medium) was removed. 
Conditioned medium was hereafter called CM-P (collected 
from RAW 264.7 cells treated with palmitate) or CM-B 
(from RAW 264.7 cells treated only with BSA as a 
control). We also obtained conditioned medium from 
RAW 264.7 cells treated with oleate, a well-known 
nontoxic monounsaturated FFA. This conditioned medium 
was hereafter called CM-O (collected from RAW 264.7 
cells treated with oleate). Once the conditioned media 
were prepared, they were added for 24 h to human 
hepatocytes and after that these cells were stimulated with 
10 nM insulin for 10 min. As depicted in Figure 1, insulin 
induced IR tyrosine phosphorylation and Akt 
phosphorylation at both residues were enhanced in 
hepatocytes preincubated with CM-O as compared to 
control hepatocytes preincubated with control CM-B. 
Conversely, IR tyrosine and Akt serine/threonine 
phosphorylations were reduced in presence of CM-P. 
Moreover, protein levels of IR and IRS1 decreased only in 
hepatocytes treated with CM-P. Altogether, these results 
indicate opposite effects of palmitate and oleate in 
triggering a cross-talk between macrophages and 
hepatocytes with relevant effects in insulin signaling. 
3.2 Differential effects of palmitate and oleate in levels of 
proinflammatory cytokines expressed by macrophages  
In order to confirm the differential effects of oleate and 
palmitate in a physiological context, we isolated and 
cultured Kupffer cells from C57/BL6 mice and these 
resident macrophages were stimulated with oleate or 
palmitate for 24 h. The purity of Kupffer cells was 
checked by the analysis of CD68 and F4/80 mRNA levels 
(Figure 2). 
In an attempt to characterize the molecules released by 
macrophages to the CM, we assessed the expression of 
proinflammatory cytokines characteristic of M1 
macrophage polarization by real-time PCR. Treatment of 
Kupffer cells with palmitate, but not oleate, increased IL6, 
IL1β, TNFα and MCP1 mRNA levels. On the other hand, 
treatment with oleate significantly up-regulated mRNA 
levels of M2 polarization markers (IL10, Mcr1, Mgl1 and 
arginase 1) (Figure 3). 
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Figure 1. Insulin signaling is differentially modulated in human hepatocytes pretreated with CM-O or CM-P. Conditioned medium 
from RAW 264.7 macrophages treated with BSA (CM-B), oleate (CM-O) or palmitate (CM-P) was added to human primary hepatocytes 
for 24 h. Then, cells were stimulated with 10 nM insulin for 10 min. Total protein was analyzed by Western blot using the indicated 
antibodies. Representative blots are shown. (n=4 independent experiments performed in duplicate). 
 
Figure 2. Purity of Kupffer cells. Kupffer cells and hepatocytes were isolated from mice as described in the Experimental Procedures 
and mRNA levels of CD68 and F4/80 were determined. CD68 and F4/80 were undetectable in hepatocytes (n=3 independent experiments 
performed in duplicate). 
 
Figure 3. Expression of cytokines and markers of inflammation from Kupffer cells. Primary Kupffer cells were treated with BSA 
(B), oleate (O) or palmitate (P) for 24 h. TNFα, IL-6, IL-1β, MCP1, IL-10, arginase 1, Mcr1 and Mgl1 mRNA levels were analyzed by 
qRT-PCR. Results are expressed as fold increase relative to BSA condition (1) and are mean ± SEM (n=3), *p<0.05, **p<0.01, O or P, 
respectively, vs B. 
3.3. Conditioned medium from Kupffer cells stimulated 
with palmitate activates stress-mediated signaling 
pathways 
Next, we confirmed data on proinflammatory cytokines 
by analyzing the activation of stress kinases in primary 
mouse hepatocytes treated with CM from Kupffer 
macrophages stimulated with oleate or palmitate (CMK-O 
or CMK-P, respectively). As a control, hepatocytes were 
stimulated with CM from Kupffer cells loaded with BSA 
(CMK-B). As shown in Figure 4, phosphorylations of 
STAT3, p38 MAPK, JNK, PERK and eIF2α were 
observed exclusively in hepatocytes treated with CMK-P. 
Virginia Pardo Marqués, Águeda González-Rodríguez, Ángela Martínez Valverde 
@Real Academia Nacional de Farmacia. Spain 204 
 
Figure 4. Paracrine effects of primary Kupffer cells 
stimulated with palmitate or oleate in stress pathways in 
primary mouse hepatocytes. Conditioned medium from primary 
Kupffer cells treated with BSA (CMK-B), oleate (CMK-O) or 
palmitate (CMK-P) was added to primary mouse hepatocytes for 
30 min. Total protein was analyzed by Western blot using the 
indicated antibodies. Representative blots are shown (n=3 
independent experiments. 
In the light of these data, CHOP and the active 
fragment of caspase 3, indicators of apoptosis, also were 
detected only in hepatocytes treated with CMK-P (Figure 
5). 
 
Figure 5. Paracrine effects of primary Kupffer cells 
stimulated with palmitate or oleate in lipoapoptotic pathways 
in primary mouse hepatocytes. Conditioned medium from 
primary Kupffer cells treated with BSA (CMK-B), oleate (CMK-
O) or palmitate (CMK-P) was added to primary mouse 
hepatocytes for 24 h. Total protein was analyzed by Western blot 
using the indicated antibodies. Representative blots are shown 
(n=3 independent experiments. 
3.4. CMK-P induces insulin resistance, whereas that 
CMK-O induces insulin hipersensitivity in primary mouse 
hepatocytes 
Next, we analyzed the effects of Kupffer cells-derived 
products on insulin signaling in hepatocytes. For this goal, 
primary hepatocytes were treated with CMK-P or CMK-O 
for 24 h and subsequently stimulated with 10 nM insulin 
for 10 min. As depicted in Figure 6, insulin-induced 
tyrosine phosphorylation of the IR and Akt 
phosphorylation at both Ser 473 and Thr 308 residues was 
enhanced in hepatocytes pretreated with CMK-O whereas 
these responses were decreased in hepatocytes pretreated 
with CMK-P. These results also reflect an opposite 
paracrine cross-talk between hepatocytes and resident 
macrophages. 
 
Figure 6. Paracrine effects of primary Kupffer cells stimulated with palmitate or oleate in insulin signaling in primary mouse 
hepatocytes. CMK was added to primary hepatocytes for 24 h. Then, cells were stimulated with 10 nM insulin for 10 min. Total protein 
was analyzed by Western blot using the indicated antibodies. Representative blots are shown (n=3 independent experiments. 
3.5. Lower levels of PTP1B can contribute to the insulin 
sensitization induced by CM-O in hepatocytes.  
Next, we evaluated the possibility that changes in the 
expression of negative modulators of the early steps of the 
insulin signaling could account for the insulin sensitization 
induced by CM-O or CMK-O in hepatocytes. Among 
them, PTP1B was a potential candidate given its ability to 
directly dephosphorylate tyrosine residues of the IR (48). 
Consistent with this hypothesis, we measured the 
expression of this phosphatase in hepatocytes incubated 
with CM-O. For these experiments we used immortalized 
neonatal hepatocytes previously generated and validated in 
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our laboratory (57). As depicted in Figure 7, PTP1B 
protein content was decreased in hepatocytes treated with 
CM-O. 
 
Figure 7. Lower levels of PTP1B contribute to the insulin sensitization induced by CM-O in hepatocytes. Conditioned medium from 
RAW 264.7 macrophages treated with BSA (CM-B) or oleate (CM-O) was added to immortalized mouse hepatocytes for 24 h. Total 
protein was analyzed by Western blot using the indicated antibodies. Representative blots are shown. After quantification of all blots, 
results are expressed as percentage of protein expression relative to CM-B condition (100%) and are mean ± SEM (n=3 independent 
experiments performed in duplicate), ***p<0.001 CM-O vs CM-B. 
As expected, insulin signaling was enhanced in 
immortalized neonatal hepatocytes preincubated with CM-
O whereas impaired insuling signaling was detected in 
cells pretreated with CM-P (Figure 8). 
 
Figure 8. Insulin signaling is differentially modulated in 
hepatocytes pretreated with conditioned medium from RAW 
264.7 macrophages stimulated with oleate or palmitate. 
Conditioned medium from RAW 264.7 macrophages treated with 
BSA (CM-B), oleate (CM-O) or palmitate (CM-P) was added to 
immortalized mouse hepatocytes for 24 h. Then, cells were 
stimulated with 10 nM insulin for 10 min. Total protein was 
analyzed by Western blot using the indicated antibodies. 
Representative blots are shown (n=4 experiments performed in 
duplicate). 
DISCUSSION 
In obesity-associated insulin resistance, M1-like 
macrophages polarization state has been associated with 
the enhancement of the proinflammatory milieu by the 
ability to secrete proinflammatory cytokines. This 
surrounding insulin resistant adipocytes that trigger 
proinflammatory signaling pathways in macrophages 
trough their binding to Toll-like receptors (TLRs) (32-34). 
However, we know now that beyond the interplay between 
adipocytes and adipose tissue resident macrophages, these 
inflammatory signals also dysregulate key metabolic 
responses in other peripheral tissues, thereby exacerbating 
insulin resistance (3). 
The liver is a target organ of the inflammatory 
mediators. In obesity, the hepatic lipid accumulation (first 
hit) together with the proinflammatory input (second hit) 
trigger the necroinflammatory changes that are recognized 
histopahologically as steatohepatitis (NASH) (35). Of 
relevance, adipose tissue inflammation has been correlated 
with hepatic steatosis in humans (36). Furthermore, 
activation of Kupffer cells, the hepatic resident 
macrophages, to secrete proinflammatory mediators is a 
key event in the initiation of NAFLD, and limiting their 
polarization into an M1 phenotype is considered an 
attractive strategy against chronic liver inflammation (37-
40).  
In this study, we have dissected for the first time the 
molecular cross-talk between signals emerging from 
macrophage-derived products in response to fatty acid 
overload and insulin signaling in hepatocytes. A step 
further, we attempted to compare the responses of 
hepatocytes to macrophage-secreted cytokines derived 
from oleate or palmitate together with FFAs mimicking the 
circulating proinflammatory milieu. Interestingly, an 
opposite response in insulin-mediated IR tyrosine 
phosphorylation, the earliest event in the insulin signaling 
cascade, was found in both mouse and human hepatocytes 
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exposed to the CM from macrophages or Kuppfer cells 
treated with oleate or palmitate, with a significant increase 
or decrease, respectively, as compared to control 
hepatocytes (treated with CM-B). This opposite response 
was also evidenced in Akt phosphorylation (at both Ser 
473 and Thr 308), a critical node of insulin´s metabolic 
actions in hepatic cells (41). Thus, these results suggested 
that oleate and palmitate induce different secretory 
responses in peripheral and liver resident macrophages and 
this might differentially modulate insulin signaling in liver 
cells. In the light of these findings, the M1 polarization 
state induced by palmitate, reflected by elevated TNFα, 
IL6, IL1β and MCP1 in agreement to Samokhvalov et al. 
(26), was not observed in Kupffer cells loaded with oleate. 
The absence of M1 polarization is critical to understand 
the modulation of insulin signaling by oleate in 
hepatocytes as will be discussed below. In fact, increased 
arginase 1, Mrc1, Mgl1 and IL10 levels reflects a M2 
profile of macrophages after oleate challenge in agreement 
with recent results reported by Camell et al. on the role of 
dietary oleic acid in M2 macrophages polarization (42).  
The ER plays a central role in the determination of cell 
fate under conditions of stress. Increased ER stress has 
been shown to contribute to the development of NAFLD 
(17). In this regard, CM-P-treated hepatocytes rapidly 
activated the PERK branch of UPR by inducing PERK, 
eIF2α and JNK phosphorylation, resulting in increased 
CHOP expression. Under these experimental conditions, 
STAT3 phosphorylation was also increased, this response 
is probably mediated by the proinflammatory cytokines 
IL6 and IL1β. Moreover, TNFα-mediating signaling might 
also boost JNK and p38 MAPK activation. The 
convergence of all these proinflammatory signaling 
cascades leads to a negative-cross talk with insulin 
signaling resulting in the degradation of both IR and IRS1 
that agrees with results reported in hepatocytes treated 
with palmitate (43, 44). Therefore, lower IR and IRS1 
levels detected in hepatocytes stimulated with CM-P 
evidence the contribution of the early activation of stress 
kinases in the reduced insulin-mediated Akt 
phosphorylation. Neither the early activation of stress 
kinases nor CHOP expression were detected in 
hepatocytes treated with CM-O, highlighting the absence 
of oleate-mediated proinflammatory responses in the 
macrophage-hepatocyte axis. 
In addition to inflammation, FFAs-induced lipotoxicity 
contributes to the pathogenesis of NAFLD, being saturated 
FFAs the more toxic lipid species (45-47). Although the 
evaluation of the apoptotic responses under inflammatory 
conditions was not the major goal of this study, we 
detected cleavage of caspase 3 in hepatocytes treated with 
CM-P, suggesting that the signals derived from the 
macrophage M1 polarization are likely involved in 
lipoapoptosis. This interesting issue deserves future 
research. 
Although PTP1B has been involved in obesity and 
inflammation (48-50), this is the first study showing the 
modulation of PTP1B protein levels by a macrophage-
derived lipid product from oleate since reduced levels of 
LTB4 in CM-O paralleled with decreased PTP1B and 
enhancement of insulin-mediated IR tyrosine 
phosphorylation in hepatocytes. These data might be of 
relevance since PTP1B has emerged as a therapeutic target 
against obesity-mediated insulin resistance by its ability to 
regulate peripheral (muscle and liver) insulin sensitivity 
(49, 51-56) as well as the central control of appetite and 
energy expenditure (48, 57, 58). Based on that, our 
ongoing research is focused on the modulation of PTP1B 
expression by bioactive lipid species (eicosanoids) in 
hepatocytes. 
In summary, we have demonstrated a paracrine cross-
talk from macrophages/Kupffer cells to hepatocytes, which 
bears opposite differences depending on the polarization 
state of the macrophages and the factors secreted by these 
immune cells as it has been manifested upon treatment 
with palmitate or oleate. To our knowledge and as 
summarized in Figure 9, this is the first study providing 
data of the beneficial effects of oleate in switching 
macrophages polarization to increase insulin sensitization 
in hepatocytes through decreasing PTP1B. Therefore, 
targeting PTP1B is a therapeutic strategy to combat 
hepatic insulin resistance in obesity. 
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Figure 9. A. Schematic representation of palmitate-induced M1 polarization of macrophages that leads to a negative cross-talk with 
hepatic insulin signaling through decreasing IR and IRS1. B. Schematic representation of the beneficial effects of oleate in switching 
macrophages polarization by inducing M2 state to enhance insulin sensitivity in hepatocytes. 
4. CONCLUSIONS  
- Palmitate treated macrophages/Kuppfer cells have 
increased expression of proinflammatory cytokines. 
- The CM-P/CMK-P leads to activation of stress 
pathways and result in insulin resistance in human and 
murine hepatocytes. 
- Oleate treated macrophages/Kuppfer cells express 
markers of antiinflammatory activity. 
- The CM-O/CMK-O produces a hypersensitivity to 
insulin in human and murine hepatocytes probably by 
lower levels of PTP1B. 
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